{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:12:39Z","timestamp":1790521959012,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["140269\/2018-5"],"award-info":[{"award-number":["140269\/2018-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melanoma is an aggressive cancer with fast metastatic spread and reduced survival time. One common event during the neoplastic progression is the epithelial\u2013mesenchymal transition (EMT), which enhances invasiveness, cell migration, and metastasis. In this study, we investigated the effects of metformin at EMT in melanoma cell lines B16-F10 and A-375, in vitro, and the impact of EMT downregulation on melanoma progression in vivo. The metformin cells treatment reduces the migration potential in vitro and reduced the development of pulmonary metastases and the expressions of N-cadherin, vimentin, ZEB1, and ZEB2 at the metastases site, in vivo. These results indicate that metformin can promote EMT downregulation impairing the metastatic potential of melanoma cells.<\/jats:p>","DOI":"10.1038\/s41598-022-22235-8","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T13:05:16Z","timestamp":1666443916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epithelial\u2013mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model"],"prefix":"10.1038","volume":"12","author":[{"given":"Emerson Soares","family":"Veloso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Andrade","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Henrique","family":"de Souza Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Salviana","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Mendes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Pereira","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edtor Henrique Soares Rom\u00e3o","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Aparecida","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Rios","family":"de Ara\u00fajo Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Lima","family":"Del Puerto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"22235_CR1","volume-title":"Cancer Facts & Figures 2019","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Cancer Facts & Figures 2019 (American Cancer Society (American Cancer Society, 2019)."},{"key":"22235_CR2","unstructured":"INCA. C\u00e2ncer de pele melanoma. https:\/\/www.inca.gov.br\/tipos-de-cancer\/cancer-de-pele-melanoma (2020)."},{"key":"22235_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.abb.2011.10.020","volume":"524","author":"S Kuphal","year":"2012","unstructured":"Kuphal, S. & Bosserhoff, A. K. E-cadherin cell-cell communication in melanogenesis and during development of malignant melanoma. Arch. Biochem. Biophys. 524, 43\u201347 (2012).","journal-title":"Arch. Biochem. Biophys."},{"key":"22235_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R.Y.-J., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"22235_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/00313020701329914","volume":"39","author":"M Guarino","year":"2007","unstructured":"Guarino, M., Rubino, B. & Ballabio, G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39, 305\u2013318 (2007).","journal-title":"Pathology"},{"key":"22235_CR6","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1365-2133.2012.10824.x","volume":"166","author":"L Hao","year":"2012","unstructured":"Hao, L., Ha, J. R., Kuzel, P., Garcia, E. & Persad, S. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K\/PTEN pathway through Twist and Snail. Br. J. Dermatol. 166, 1184\u20131197 (2012).","journal-title":"Br. J. Dermatol."},{"key":"22235_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16021","author":"D Pedri","year":"2021","unstructured":"Pedri, D., Karras, P., Landeloos, E., Marine, J. & Rambow, F. Epithelial-to-mesenchymal-like transition events in melanoma. FEBS J. https:\/\/doi.org\/10.1111\/febs.16021 (2021).","journal-title":"FEBS J."},{"key":"22235_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel, J. et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466\u2013480 (2013).","journal-title":"Cancer Cell"},{"key":"22235_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"BD Craene","year":"2013","unstructured":"Craene, B. D. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97\u2013110 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"22235_CR10","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cdd.2014.44","volume":"21","author":"G Denecker","year":"2014","unstructured":"Denecker, G. et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death Differ. 21, 1250\u20131261 (2014).","journal-title":"Cell Death Differ."},{"key":"22235_CR11","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal, M., Lee, E. S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910\u201314914 (2008).","journal-title":"J. Biol. Chem."},{"key":"22235_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JMM Evans","year":"2005","unstructured":"Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R. & Morris, A. D. Metformin and reduced risk of cancer in diabetic patients. BMJ 330, 1304\u20131305 (2005).","journal-title":"BMJ"},{"key":"22235_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","volume":"29","author":"SL Bowker","year":"2006","unstructured":"Bowker, S. L., Majumdar, S. R., Veugelers, P. & Johnson, J. A. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29, 254\u2013258 (2006).","journal-title":"Diabetes Care"},{"key":"22235_CR14","doi-asserted-by":"publisher","first-page":"40767","DOI":"10.18632\/oncotarget.8194","volume":"7","author":"YK Chae","year":"2016","unstructured":"Chae, Y. K. et al. Repurposing metformin for cancer treatment: Current clinical studies. Oncotarget 7, 40767\u201340780 (2016).","journal-title":"Oncotarget"},{"key":"22235_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5604\/01.3001.0010.3801","volume":"71","author":"M Podhorecka","year":"2017","unstructured":"Podhorecka, M., Ibanez, B. & Dmoszy\u0144ska, A. Metformin\u2014Its potential anti-cancer and anti-aging effects. Postepy Hig Med. Dosw. 71, 170\u2013175 (2017).","journal-title":"Postepy Hig Med. Dosw."},{"key":"22235_CR16","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1535-7163.MCT-12-1226-T","volume":"12","author":"M Cerezo","year":"2013","unstructured":"Cerezo, M. et al. Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner. Mol. Cancer Ther. 12, 1605\u20131615 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"22235_CR17","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/15384101.2016.1191706","volume":"15","author":"S Peppicelli","year":"2016","unstructured":"Peppicelli, S. et al. Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation. Cell Cycle 15, 1908\u20131918 (2016).","journal-title":"Cell Cycle"},{"key":"22235_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/pcmr.12267","volume":"28","author":"M Cerezo","year":"2014","unstructured":"Cerezo, M., Tomic, T., Ballotti, R. & Rocchi, S. Is it time to test biguanide metformin in the treatment of melanoma?. Pigment Cell Melanoma Res. 28, 8\u201320 (2014).","journal-title":"Pigment Cell Melanoma Res."},{"key":"22235_CR19","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3892\/ol.2015.3475","volume":"10","author":"G Liang","year":"2015","unstructured":"Liang, G. et al. Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration. Oncol. Lett. 10, 1527\u20131532 (2015).","journal-title":"Oncol. Lett."},{"key":"22235_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/cancers11020209","volume":"11","author":"H-W Tseng","year":"2019","unstructured":"Tseng, H.-W., Li, S.-C. & Tsai, K.-W. Metformin treatment suppresses melanoma cell growth and motility through modulation of microRNA expression. Cancers 11, 209 (2019).","journal-title":"Cancers"},{"key":"22235_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128\u2013134 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"22235_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"22235_CR23","first-page":"1203","volume":"19","author":"C Zhang","year":"2019","unstructured":"Zhang, C. & Wang, Y. Metformin attenuates cells stemness and epithelial-mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a\/\u03b2-catenin pathway. Mol. Med. Rep. 19, 1203\u20131209 (2019).","journal-title":"Mol. Med. Rep."},{"key":"22235_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"22235_CR25","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1016\/j.biopha.2018.11.109","volume":"109","author":"O Ryabaya","year":"2019","unstructured":"Ryabaya, O. et al. Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. Biomed. Pharmacother. 109, 2548\u20132560 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"22235_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s11658-022-00353-5","volume":"27","author":"D Suwei","year":"2022","unstructured":"Suwei, D. et al. Metformin inhibits melanoma cell metastasis by suppressing the miR-5100\/SPINK5\/STAT3 axis. Cell Mol. Biol. Lett. 27, 48 (2022).","journal-title":"Cell Mol. Biol. Lett."},{"key":"22235_CR27","doi-asserted-by":"publisher","first-page":"100970","DOI":"10.1016\/j.tranon.2020.100970","volume":"14","author":"MG Alves","year":"2021","unstructured":"Alves, M. G. et al. Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma. Transl. Oncol. 14, 100970 (2021).","journal-title":"Transl. Oncol."},{"key":"22235_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","volume":"40","author":"W-H Lin","year":"2021","unstructured":"Lin, W.-H. et al. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT\u2013MET switch and cancer metastasis. Oncogene 40, 791\u2013805 (2021).","journal-title":"Oncogene"},{"key":"22235_CR29","doi-asserted-by":"publisher","unstructured":"Pillai, M. et al. Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis. Front. Oncol. 12. https:\/\/doi.org\/10.3389\/fonc.2022.913803 (2022).","DOI":"10.3389\/fonc.2022.913803"},{"key":"22235_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00418-017-1606-0","volume":"148","author":"D Murtas","year":"2017","unstructured":"Murtas, D. et al. Role of epithelial\u2013mesenchymal transition involved molecules in the progression of cutaneous melanoma. Histochem. Cell Biol. 148, 639\u2013649 (2017).","journal-title":"Histochem. Cell Biol."},{"key":"22235_CR31","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.21873\/anticanres.11243","volume":"36","author":"S Yan","year":"2016","unstructured":"Yan, S. et al. Epithelial-mesenchymal expression phenotype of primary melanoma and matched metastases and relationship with overall survival. Anticancer Res. 36, 6449\u20136456 (2016).","journal-title":"Anticancer Res."},{"key":"22235_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ceb.2014.06.004","volume":"30","author":"S Etienne-Manneville","year":"2014","unstructured":"Etienne-Manneville, S. Neighborly relations during collective migration. Curr. Opin. Cell Biol. 30, 51\u201359 (2014).","journal-title":"Curr. Opin. Cell Biol."},{"key":"22235_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12885-018-4845-0","volume":"18","author":"KM Mrozik","year":"2018","unstructured":"Mrozik, K. M., Blaschuk, O. W., Cheong, C. M., Zannettino, A. C. W. & Vandyke, K. N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer 18, 939 (2018).","journal-title":"BMC Cancer"},{"key":"22235_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/21541248.2017.1366965","volume":"11","author":"A Combedazou","year":"2020","unstructured":"Combedazou, A. et al. Small GTPases orchestrate cell-cell communication during collective cell movement. Small GTPases 11, 103\u2013112 (2020).","journal-title":"Small GTPases"},{"key":"22235_CR35","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/biom10071040","volume":"10","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh, M. et al. MicroRNAs and their influence on the ZEB family: Mechanistic aspects and therapeutic applications in cancer therapy. Biomolecules 10, 1040 (2020).","journal-title":"Biomolecules"},{"key":"22235_CR36","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1038\/sj.onc.1203721","volume":"19","author":"ML Grooteclaes","year":"2000","unstructured":"Grooteclaes, M. L. & Frisch, S. M. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823\u20133828 (2000).","journal-title":"Oncogene"},{"key":"22235_CR37","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","volume":"7","author":"J Comijn","year":"2001","unstructured":"Comijn, J. et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267\u20131278 (2001).","journal-title":"Mol. Cell"},{"key":"22235_CR38","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1093\/nar\/gki965","volume":"33","author":"C Vandewalle","year":"2005","unstructured":"Vandewalle, C. et al. SIP1\/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 33, 6566\u20136578 (2005).","journal-title":"Nucleic Acids Res."},{"key":"22235_CR39","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.3390\/cancers12082248","volume":"12","author":"K Bruneel","year":"2020","unstructured":"Bruneel, K., Verstappe, J., Vandamme, N. & Berx, G. Intrinsic balance between ZEB family members is important for melanocyte homeostasis and melanoma progression. Cancers 12, 2248 (2020).","journal-title":"Cancers"},{"key":"22235_CR40","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1158\/0008-5472.CAN-19-2373","volume":"80","author":"N Vandamme","year":"2020","unstructured":"Vandamme, N. et al. The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype. Cancer Res. 80, 2983\u20132995 (2020).","journal-title":"Cancer Res."},{"key":"22235_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"22235_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/JID.2015.380","volume":"136","author":"V R\u00f6tzer","year":"2016","unstructured":"R\u00f6tzer, V. et al. Desmoglein 3-dependent signaling regulates keratinocyte migration and wound healing. J. Investig. Dermatol. 136, 301\u2013310 (2016).","journal-title":"J. Investig. Dermatol."},{"key":"22235_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.rvsc.2020.04.007","volume":"131","author":"ES Veloso","year":"2020","unstructured":"Veloso, E. S. et al. ZEB and Snail expression indicates epithelial-mesenchymal transition in canine melanoma. Res. Vet. Sci. 131, 7\u201314 (2020).","journal-title":"Res. Vet. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T13:08:48Z","timestamp":1666444128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22235"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22235-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,22]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17776"}}